Schedule 13G ownership disclosure
BioMarin Pharmaceutical Inc
Security class unavailable · CUSIP: 09061G101
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,254,206
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000053417-17-000015
- Form type
- SC 13G
- Filer
- BIOMARIN PHARMACEUTICAL INC
- CIK
- CIK 1048477
- Filed
- Feb 02, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership